According to Oncolytics Biotech 's latest financial reports and stock price the company's current Operating Margin is -1,631.46%. At the end of 2005 the company had an Operating Margin of -1,631.47%.
Year | Operating Margin | Change |
---|---|---|
2005 | -1,631.47% | -11.88% |
2004 | -1,851.52% | -31.84% |
2003 | -2,716.36% | -15.96% |
2002 | -3,232.38% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.